During the past decade, Apollo Neuroscience, Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Apollo Neuroscience, Inc." #1 collaborator was "The Board of Medicine" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Apollo Neuroscience, Inc." are "Heart Rate" (1 trials), "Sleep Quality" (1 trials) and "Stress Disorders, Post-Traumatic" (1 trials). Many other conditions were trialed in "Apollo Neuroscience, Inc." in a lesser frequency.

Most popular intervention types in "Apollo Neuroscience, Inc." are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apollo Wearable" (1 trials). Other intervention names were less common.

The vast majority of trials in "Apollo Neuroscience, Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Apollo Neuroscience, Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Apollo Neuroscience, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Apollo Neuroscience, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".